MedPAC proposal threatens access to medicines in Part B

Next week, the Medicare Payment Advisory Commission (MedPAC) will vote on a number of policy proposals for changing Medicare Part B. One of the proposals would recommend that Congress adjust the payment for Part B medicines withaccelerated approval, including medicines for serious and life-threatening diseases like cancers, rare diseases and HIV. This could compromise patient access to medicines, which is the opposite of what accelerated approval is designed to do. Here are three reasons why MedPAC should vote no on this proposal.
Source: The Catalyst - Category: Pharmaceuticals Tags: Medicare Part B Accelerated Approval Source Type: news